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Background
The HIV-1 gp41 MPER contains the epitopes for 4
broadly neutralizing (bNt) antibodies (Abs), making it a
target for vaccine design. We developed a panel of DNA-
vaccine candidates that link the MPER, or larger portions
of gp41’s external domain, to two different transmembrane
(TM) and cytoplasmic (CT) domains. We report on the
ability of DNA vaccines expressing these constructs to eli-
cit MPER-specific Nt Abs in rabbits.
Methods
DNA vaccines encoding various gp41 ectodomain frag-
ments, and the TM and CT of either the platelet-derived
growth factor receptor (PGDFR-TM), or the TM and
truncated CT of gp41 (TM1), were used to immunize rab-
bits; immune sera were tested for reactivity against the
MPER displayed on the cell surface and for pseudovirus
neutralization.
Results
Immunizations with plasmids expressing larger fragments
of the gp41 ectodomain tethered to the PDGFR-TM eli-
cited lower-titer Abs against the MPER, as compared to
the MPER tethered to the PDGFR-TM, which elicited
MPER-specific Abs that included those targeting the 2F5
epitope Affinity purification of these Abs on 2F5-epitope
peptide resulted in Abs that bound MPER expressed on
cells, but neutralized both pseudoviruses bearing HIV
envelope and those bearing AMLV envelope. Immuniza-
tion with DNA vaccines encoding the MPER fused to the
gp41 TM1, elicited low-titre Abs that cross-reacted weakly
with the MPER and strongly with regions in the CT. All
immunization failed to produce Abs that cross-react with
the 4E10 epitope.
Conclusion
While the initial immunization studies reported here
demonstrate that MPER reactivity is elicited by DNA
immunization, the MPER-TM1 construct appears to elicit
Abs against epitopes in its 27-aa CT domain. Current
work is focused on replacing the gp41 TM with an engi-
neered TM that will optimally expose the epitopes for the
bNt MAbs, particularly 4E10.
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